These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1024 related items for PubMed ID: 11911810
1. Ectopic expression of Bcl-2 and Bcl-xL inhibits apoptosis induced by TNF-related apoptosis-inducing ligand (TRAIL) through suppression of caspases-8, 7, and 3 and BID cleavage in human acute myelogenous leukemia cell line HL-60. Lamothe B, Aggarwal BB. J Interferon Cytokine Res; 2002 Feb; 22(2):269-79. PubMed ID: 11911810 [Abstract] [Full Text] [Related]
2. Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl-2 and Bcl-xl. Anto RJ, Mukhopadhyay A, Denning K, Aggarwal BB. Carcinogenesis; 2002 Jan; 23(1):143-50. PubMed ID: 11756235 [Abstract] [Full Text] [Related]
3. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR, Dai Y, Almenara JA, Maggio SC, Grant S. Leukemia; 2004 Nov; 18(11):1780-8. PubMed ID: 15385934 [Abstract] [Full Text] [Related]
4. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11. Ray S, Almasan A. Cancer Res; 2003 Aug 01; 63(15):4713-23. PubMed ID: 12907654 [Abstract] [Full Text] [Related]
5. TNF-related apoptosis-inducing ligand-induced apoptosis of melanoma is associated with changes in mitochondrial membrane potential and perinuclear clustering of mitochondria. Thomas WD, Zhang XD, Franco AV, Nguyen T, Hersey P. J Immunol; 2000 Nov 15; 165(10):5612-20. PubMed ID: 11067917 [Abstract] [Full Text] [Related]
6. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R, Bedi A. Cancer Res; 2002 Aug 01; 62(15):4180-5. PubMed ID: 12154014 [Abstract] [Full Text] [Related]
7. A caspase-8-independent component in TRAIL/Apo-2L-induced cell death in human rhabdomyosarcoma cells. Petak I, Vernes R, Szucs KS, Anozie M, Izeradjene K, Douglas L, Tillman DM, Phillips DC, Houghton JA. Cell Death Differ; 2003 Jun 01; 10(6):729-39. PubMed ID: 12761581 [Abstract] [Full Text] [Related]
8. Augmentation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by the synthetic retinoid 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphthalene carboxylic acid (CD437) through up-regulation of TRAIL receptors in human lung cancer cells. Sun SY, Yue P, Hong WK, Lotan R. Cancer Res; 2000 Dec 15; 60(24):7149-55. PubMed ID: 11156424 [Abstract] [Full Text] [Related]
9. Defining characteristics of Types I and II apoptotic cells in response to TRAIL. Ozören N, El-Deiry WS. Neoplasia; 2002 Dec 15; 4(6):551-7. PubMed ID: 12407450 [Abstract] [Full Text] [Related]
10. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells. Izeradjene K, Douglas L, Delaney A, Houghton JA. Clin Cancer Res; 2004 Oct 01; 10(19):6650-60. PubMed ID: 15475455 [Abstract] [Full Text] [Related]
11. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer]. Zhu HB, Huang XF, Hu JZ, Zhou W, Chen W, Chen LL, He C. Zhonghua Zhong Liu Za Zhi; 2008 Apr 01; 30(4):245-9. PubMed ID: 18788624 [Abstract] [Full Text] [Related]
12. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097 [Abstract] [Full Text] [Related]
13. Overexpression of BCL2 blocks TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in human lung cancer cells. Sun SY, Yue P, Zhou JY, Wang Y, Choi Kim HR, Lotan R, Wu GS. Biochem Biophys Res Commun; 2001 Jan 26; 280(3):788-97. PubMed ID: 11162590 [Abstract] [Full Text] [Related]
14. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S, Singh TR, Fandy TE, Luetrakul T, Ross DD, Srivastava RK. Int J Mol Med; 2005 Dec 26; 16(6):1125-38. PubMed ID: 16273296 [Abstract] [Full Text] [Related]
15. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H, Bouchon A, Stahl H, Krammer PH. Cancer Res; 2000 Jun 01; 60(11):3051-7. PubMed ID: 10850456 [Abstract] [Full Text] [Related]
16. Casein kinase I attenuates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by regulating the recruitment of fas-associated death domain and procaspase-8 to the death-inducing signaling complex. Izeradjene K, Douglas L, Delaney AB, Houghton JA. Cancer Res; 2004 Nov 01; 64(21):8036-44. PubMed ID: 15520213 [Abstract] [Full Text] [Related]
17. Drug-mediated sensitization to TRAIL-induced apoptosis in caspase-8-complemented neuroblastoma cells proceeds via activation of intrinsic and extrinsic pathways and caspase-dependent cleavage of XIAP, Bcl-xL and RIP. Mühlethaler-Mottet A, Bourloud KB, Auderset K, Joseph JM, Gross N. Oncogene; 2004 Jul 15; 23(32):5415-25. PubMed ID: 15094781 [Abstract] [Full Text] [Related]
18. Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Suliman A, Lam A, Datta R, Srivastava RK. Oncogene; 2001 Apr 19; 20(17):2122-33. PubMed ID: 11360196 [Abstract] [Full Text] [Related]
19. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related]
20. Overexpression of Bcl-2 or Bcl-xL inhibits Ara-C-induced CPP32/Yama protease activity and apoptosis of human acute myelogenous leukemia HL-60 cells. Ibrado AM, Huang Y, Fang G, Liu L, Bhalla K. Cancer Res; 1996 Oct 15; 56(20):4743-8. PubMed ID: 8840993 [Abstract] [Full Text] [Related] Page: [Next] [New Search]